Compare KFFB & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KFFB | GNTA |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5M | 34.0M |
| IPO Year | 2004 | N/A |
| Metric | KFFB | GNTA |
|---|---|---|
| Price | $4.54 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.5K | ★ 603.4K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.52 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $15,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $60.27 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.96 | $0.71 |
| 52 Week High | $4.98 | $10.00 |
| Indicator | KFFB | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 44.12 |
| Support Level | N/A | $0.71 |
| Resistance Level | N/A | $1.70 |
| Average True Range (ATR) | 0.00 | 0.11 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 77.49 |
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.